RecruitingPhase 1Phase 2NCT01953263

Muscle Fiber Fragment Treatment for Urinary Incontinence

A Phase 1 Study of Human Muscle Fiber Fragment (MFF) Treatment for Urinary Incontinence


Sponsor

Wake Forest University

Enrollment

10 participants

Start Date

Jan 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

This study is designed to evaluate the safety of autologous muscle fiber fragments for the treatment of urinary incontinence due to incompetent outlet (bladder neck/urethra).


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Autologous Muscle Fiber Fragments for people with urinary incontinence. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAutologous Muscle Fiber Fragments

Autologous muscle fiber fragments administered via a single direct injection into the bladder neck sphincter region


Locations(1)

Wake Forest Urology Clinic

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01953263


Related Trials